CARCINOID TUMOUR OF THE CAECUM

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting CARCINOID TUMOUR OF THE CAECUM:

# Drug Count
0 AMLODIPINE 6
1 CANDESARTAN 6
2 ETANERCEPT 6
3 METHOTREXATE SODIUM 5
4 METHOTREXATE 3
5 DABIGATRAN ETEXILATE 2
6 DABIGATRAN ETEXILATE MESYLATE 2
7 DEFERASIROX 2
8 RUXOLITINIB 2
9 ANTACID 1
See all common drugs associated with CARCINOID TUMOUR OF THE CAECUM

CARCINOID TUMOUR OF THE CAECUM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ELBASVIR AND GRAZOPREVIR 1 0.0002
1 PERINDOPRIL ERBUMINE 1 0.0002
2 CANDESARTAN 6 0.0002
3 DEFERASIROX 2 0.0001
4 SOTALOL HYDROCHLORIDE 1 0.0001
5 OCTREOTIDE ACETATE 1 0.0000
6 THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE 1 0.0000
7 DABIGATRAN ETEXILATE MESYLATE 2 0.0000
8 RUXOLITINIB 2 0.0000
9 DABIGATRAN ETEXILATE 2 0.0000
See all drugs enriched for association with CARCINOID TUMOUR OF THE CAECUM